Toxicity profile of high dose methotrexate (HD-MTX) in osteosarcoma (OS) patients

被引：0
|
作者：
Samur, M [1 ]
Parrir, A [1 ]
Arican, A [1 ]
Sencan, O [1 ]
机构：
[1] Ankara Univ, Fac Med, Dept Med Oncol, TR-06100 Ankara, Turkey
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP164
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [21] PHARMACOLOGICAL COMPARISON OF HIGH-DOSE METHOTREXATE (HD-MTX) ADMINISTERED IN 1 HOUR AND 18 HOUR INFUSIONS
    LICHTER, JG
    SANTICKY, MA
    JACOBS, SA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 441 - 441
  • [22] IS NON-HIGH DOSE-METHOTREXATE (HD-MTX) BASED, DOSE-DENSE, COMBINATION CHEMOTHERAPY (CT) A VALID CHOICE IN HIGH TUMOR BURDEN AND NUTRITIONALLY CHALLENGED OSTEOSARCOMA?
    Bajpai, J.
    Chandrakanth, M. V.
    Agarwala, V.
    D'souza, S.
    Puri, A. J. A. Y.
    Rekhi, B.
    Chinnaswamy, G.
    Laskar, S.
    Banavali, S.
    Gupta, S.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S177 - S177
  • [23] Simplified preanalytical laboratory procedures for therapeutic drug monitoring (TDM) in patients treated with high-dose methotrexate (HD-MTX) and glucarpidase
    Knoernschild, Franz L.
    Liebig, Sven
    Kiessling, Peggy
    Prpic, Monika
    Kim, Tehyung
    Keller, Ulrich
    Kappert, Kai
    Schwartz, Stefan
    Jahic, Amir
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2024,
  • [24] COMPARATIVE OUTCOME OF CHILDHOOD OSTEOSARCOMA TREATED WITH 2 CONSECUTIVE PROTOCOLS: HIGHLIGHTING THE EFFECTIVENESS OF HIGH-DOSE METHOTREXATE (HD-MTX) IN A SINGLE INSTITUTE'S EXPERIENCE
    Worawut, C.
    Pakakasama, S.
    Hongeng, S.
    Hutsadol, S.
    Sirachainan, N.
    Chuansumrit, A.
    Anurathapan, U.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 88 - 88
  • [25] Non- High Dose -Methotrexate (HD-MTX) Based, Dose-Dense (DD), Combination, Chemotherapy(CT) in 83 Metastatic Osteosarcoma Patients: A Tertiary Care Centre Experience from India
    Bajpai, J.
    Talreja, V.
    Karpe, A.
    Vora, T.
    Rekhi, B.
    Gupta, S.
    Banavali, S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S121 - S121
  • [26] HIGH DOSE METHOTREXATE (HD-MTX) IN TREATMENT OF EXTRA-RENAL RHABDOID TUMOR (ERRT) WITH DIFFUSE LEPTOMENINGEAL SPREAD
    Saeed, Haleema
    Hord, Jeffrey
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S80 - S80
  • [27] Relationship Between the Free and Total Methotrexate Plasma Concentration in Children and Application to Predict the Toxicity of HD-MTX
    Dong, Wei-Chong
    Guo, Jia-Liang
    Wu, Xi-Kun
    Zhao, Meng-Qiang
    Li, Hao-Ran
    Zhang, Zhi-Qing
    Jiang, Ye
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [28] IMPROVED SURVIVAL IN PATIENTS WITH ADVANCED SQUAMOUS CARCINOMA OF HEAD AND NECK RESPONDING TO PREOPERATIVE HIGH-DOSE METHOTREXATE-LEUKOVORIN (HD-MTX)
    ERVIN, TJ
    MILLER, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 141 - 141
  • [29] High dose methotrexate (HDMTX) pharmacokinetic profile in osteosarcoma patients
    Comandone, A
    Boglione, A
    Bacci, G
    Oliva, C
    Bergnolo, P
    Leone, L
    Ferrari, S
    Bumma, C
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1128 - 1128
  • [30] Methotrexate (MTX) serum peak monitoring in patients with osteosarcoma treated with high-dose methotrexate chemotherapy
    Landre, Thierry
    Cras, Audrey
    El Ghessassi, Ibrahim
    Mourez, Thomas
    Martre, Helene Sauvageon
    Faure, Pierre
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 499 - 499
12345